ID   BT-16
AC   CVCL_M156
SY   BT16
DR   cancercelllines; CVCL_M156
DR   Cell_Model_Passport; SIDM01521
DR   DepMap; ACH-001020
DR   PharmacoDB; BT16_119_2019
DR   Wikidata; Q54798449
RX   PubMed=17446062;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Biegel J.; Children's Hospital of Philadelphia; Philadelphia; USA.
CC   Omics: Deep exome analysis.
DI   NCIt; C6906; Atypical teratoid/rhabdoid tumor
DI   ORDO; Orphanet_99966; Atypical teratoid rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 05-10-23; Version: 12
//
RX   PubMed=17446062; DOI=10.1016/j.ejca.2007.03.003;
RA   D'cunja J., Shalaby T., Rivera P., von Bueren A.O., Patti R.,
RA   Heppner F.L., Arcaro A., Rorke-Adams L.B., Phillips P.C.,
RA   Grotzer M.A.;
RT   "Antisense treatment of IGF-IR induces apoptosis and enhances
RT   chemosensitivity in central nervous system atypical teratoid/rhabdoid
RT   tumours cells.";
RL   Eur. J. Cancer 43:1581-1589(2007).
//